Tracking chromatin state changes using nanoscale photo-proximity labelling
Nature · 20.04.2023 · 616 (7957) · 574-580
DOI: 10.1038/s41586-023-05914-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 05.04.2023. Verfasst von Ciaran P Seath und 6 weiteren Autor:innen. Beteiligte Einrichtung: Merck Center for Catalysis at Princeton University, Princeton, NJ, USA. Hauptthemen laut MEDLINE: Cell Nucleus, Chromatin, Cross-Linking Reagents. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Interactions between biomolecules underlie all cellular processes and ultimately control cell fate. Perturbation of native interactions through mutation, changes in expression levels or external stimuli leads to altered cellular physiology and can result in either disease or therapeutic effects1,2. Mapping these interactions and determining how they respond to stimulus is the genesis of many drug development efforts, leading to new therapeutic targets and improvements in human health1. However, in the complex environment of the nucleus, it is challenging to determine protein-protein interactions owing to low abundance, transient or multivalent binding and a lack of technologies that are able to interrogate these interactions without disrupting the protein-binding surface under study3. Here, we describe a method for the traceless incorporation of iridium-photosensitizers into the nuclear micro-environment using engineered split inteins. These Ir-catalysts can activate diazirine warheads through Dexter energy transfer to form reactive carbenes within an approximately 10 nm radius, cross-linking with proteins in the immediate micro-environment (a process termed µMap) for analysis using quantitative chemoproteomics4. We show that this nanoscale proximity-labelling method can reveal the critical changes in interactomes in the presence of cancer-associated mutations, as well as treatment with small-molecule inhibitors. µMap improves our fundamental understanding of nuclear protein-protein interactions and, in doing so, is expected to have a significant effect on the field of epigenetic drug discovery in both academia and industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Merck Center for Catalysis at Princeton University, Princeton, NJ, USA.
- Department of Chemistry, Princeton University, Princeton, NJ, USA.
- Department of Chemistry, Scripps-UF, Jupiter, FL, USA.
- Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
- Merck Center for Catalysis at Princeton University, Princeton, NJ, USA. dmacmill@princeton.edu.
- Department of Chemistry, Princeton University, Princeton, NJ, USA. dmacmill@princeton.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Seath, C. P., Burton, A. J., Sun, X., Lee, G., Kleiner, R. E., MacMillan, D. W. C., & Muir, T. W. (2023). Tracking chromatin state changes using nanoscale photo-proximity labelling. Nature, 616(7957), 574-580. https://doi.org/10.1038/s41586-023-05914-y
Vancouver
Seath CP, Burton AJ, Sun X, Lee G, Kleiner RE, MacMillan DWC, et al. Tracking chromatin state changes using nanoscale photo-proximity labelling. Nature. 2023;616(7957):574-580. doi:10.1038/s41586-023-05914-y
BibTeX
@article{Seath2023,
author = {Seath, Ciaran P and Burton, Antony J and Sun, Xuemeng and Lee, Gihoon and Kleiner, Ralph E and MacMillan, David W C and Muir, Tom W},
title = {Tracking chromatin state changes using nanoscale photo-proximity labelling},
journal = {Nature},
year = {2023},
volume = {616},
number = {7957},
pages = {574--580},
doi = {10.1038/s41586-023-05914-y}
}
EUVIMED